Insider · CIK 0001786372

Parrish Jay

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001786372

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-04-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,629 sh	$1.49	+$6,874.065	13,889
2021-04-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,315 sh	$1.57	+$3,646.125	16,204
2021-04-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,944 sh	$51.40	−$357K	9,260
2021-04-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,629 sh	—	—	4,630
2021-04-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,315 sh	—	—	37,037
2021-03-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,630 sh	$1.49	+$6,875.55	13,890
2021-03-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,314 sh	$1.57	+$3,644.55	16,204
2021-03-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,944 sh	$63.44	−$441K	9,260
2021-03-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,630 sh	—	—	9,259
2021-03-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,314 sh	—	—	39,352
2021-02-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,314 sh	$1.49	+$3,436.29	224,536
2021-02-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,630 sh	$1.57	+$7,292.25	229,166
2021-02-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,944 sh	$69.91	−$485K	222,222
2021-02-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,314 sh	—	—	13,889
2021-02-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,630 sh	—	—	41,666
2021-01-04	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+6,945 sh	$1.49	+$10.3K	229,167
2021-01-04	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,945 sh	$26.32	−$183K	222,222
2020-12-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,630 sh	$1.49	+$6,875.55	226,852
2020-12-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,315 sh	$1.57	+$3,646.125	229,167
2020-12-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,945 sh	$31.53	−$219K	222,222
2020-12-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,630 sh	—	—	23,148
2020-12-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,315 sh	—	—	46,296
2020-12-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−6,945 sh	—	—	16,203
2020-11-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,629 sh	$1.49	+$6,874.065	226,851
2020-11-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,315 sh	$1.57	+$3,646.125	229,166
2020-11-02	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,944 sh	$31.27	−$217K	222,222
2020-11-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,629 sh	—	—	27,778
2020-11-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,315 sh	—	—	48,611
2020-10-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+4,630 sh	$1.49	+$6,875.55	226,852
2020-10-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+2,315 sh	$1.57	+$3,646.125	229,167
2020-10-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,945 sh	$34.75	−$241K	222,222
2020-10-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,630 sh	—	—	32,407
2020-10-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−2,315 sh	—	—	50,926
2020-09-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+6,943 sh	$1.57	+$10.9K	229,165
2020-09-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−6,943 sh	$39.15	−$272K	222,222
2020-09-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−6,943 sh	—	—	53,241
2020-08-03	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+9,259 sh	$1.49	+$13.7K	231,481
2020-08-03	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+1,851 sh	$1.57	+$2,915.325	233,332
2020-08-03	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−11.1K sh	$47.65	−$529K	222,222
2020-08-03	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−9,259 sh	—	—	37,037
2020-08-03	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−1,851 sh	—	—	60,184
2020-07-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+25.9K sh	$1.49	+$38.5K	248,147
2020-07-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+49.1K sh	$1.57	+$77.3K	297,222
2020-07-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−75K sh	$37.95	−$2.85M	222,222
2020-07-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−25.9K sh	—	—	46,296
2020-07-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−49.1K sh	—	—	62,035
2020-06-01	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+75K sh	$1.49	+$111K	297,222
2020-06-01	VIRVir Biotechnology, Inc.S Sale	Chief Business Officer	SSale	−75K sh	$35.22	−$2.64M	222,222
2020-06-01	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−75K sh	—	—	72,221
2020-05-14	VIRVir Biotechnology, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+75K sh	$1.49	+$111K	297,222

Recent filings

Accepted (ET)
Apr 54
Parrish Jay0001209191-21-025194
SEC(opens sec.gov)
Mar 34
Parrish Jay0001209191-21-016880
SEC(opens sec.gov)
Feb 125
Parrish Jay0001209191-21-010195
SEC(opens sec.gov)
Feb 24
Parrish Jay0001209191-21-006880
SEC(opens sec.gov)
Jan 54
Parrish Jay0001209191-21-001158
SEC(opens sec.gov)

Companies

Vir Biotechnology, Inc.Chief Business OfficerVIR

Address

C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500

SAN FRANCISCO, CA, 94158